PROSPECTIVE, LONGITUDINAL, NON-INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW-RISK MYELOFIBROSIS (MF) OR HIGH-RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET-DIRECTED THERAPY
Research Grant
Administered By
Duke Cancer Institute
Awarded By
Incyte Corporation
Start Date
October 2, 2017
End Date
December 28, 2023
Administered By
Duke Cancer Institute
Awarded By
Incyte Corporation
Start Date
October 2, 2017
End Date
December 28, 2023